EFG Asset Management »

Immunovant shares owned by EFG Asset Management

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by EFG Asset Management from 13F filings

Historical chart of EFG Asset Management investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by EFG Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by EFG Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1M 27k 42.13

More positions owned by EFG Asset Management

Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
IDEXX Laboratories (IDXX)
Veeva Sys Cl A Com (VEEV)
NVIDIA Corporation (NVDA)
Intuitive Surgical Com New (ISRG)
Meta Platforms Cl A (META)
Natera (NTRA)
BioMarin Pharmaceutical (BMRN)
Veracyte (VCYT)
Costco Wholesale Corporation (COST)
Broadcom (AVGO)
Chipotle Mexican Grill (CMG)
Visa Com Cl A (V)

View all positions for EFG Asset Management

Top funds holding Immunovant

Vanguard Group
Point72 Asset Management
Perceptive Advisors
T. Rowe Price Associates
Alpine Partners VI
Logos Global Management
Cormorant Asset Management
Citadel Advisors
Commodore Capital
Boxer Capital
Redmile Group
Fred Alger Management
Millennium Management
Dimensional Fund Advisors
Ikarian Capital

View all funds holding Immunovant